Cargando…

Histopathological Analysis of Nodal Disease After Chemoradiation Reveals Viable Tumor Cells as the most Important Prognostic Factor in Head and Neck Squamous Cell Carcinoma

BACKGROUND: In head and neck squamous cell carcinoma (HNSCC), salvage neck dissection (ND) is required after primary chemoradiation in case of residual nodal disease. Upon histopathological examination, viability of tumor cells is assessed but little is known about other prognostic histopathological...

Descripción completa

Detalles Bibliográficos
Autores principales:	Golliez, Aline, Morand, Grégoire B., Broglie, Martina A., Balermpas, Panagiotis, Rupp, Niels J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10514022/ https://www.ncbi.nlm.nih.gov/pubmed/37195519 http://dx.doi.org/10.1007/s12105-023-01557-7

Ejemplares similares

Histopathological Analysis of Nodal Disease After Chemoradiation Reveals Viable Tumor Cells as the most Important Prognostic Factor in Head and Neck Squamous Cell Carcinoma, DOI 10.1007/s12105-023-01557-7
por: Morand, Grégoire B., et al.
Publicado: (2023)

A dataset on patient-individual lymph node involvement in oropharyngeal squamous cell carcinoma
por: Ludwig, Roman, et al.
Publicado: (2022)

Need for adjuvant radiotherapy in oral cancer: depth of invasion rather than tumor diameter
por: Riemenschnitter, Cosima E., et al.
Publicado: (2022)

Value of SUV(max) for the Prediction of Bone Invasion in Oral Squamous Cell Carcinoma
por: Stalder, Stephanie A., et al.
Publicado: (2020)

Predictive value of suvmax changes between two sequential post-therapeutic FDG-pet in head and neck squamous cell carcinomas
por: Stadler, Thomas M., et al.
Publicado: (2020)

Correction: Stalder, et al.; Value of SUV(max) for the Prediction of Bone Invasion in Oral Squamous Cell Carcinoma. Biology 2020, 9, 23
por: Stalder, Stephanie A., et al.
Publicado: (2020)

Histometabolic Tumor Imaging of Hypoxia in Oral Cancer: Clinicopathological Correlation for Prediction of an Aggressive Phenotype
por: Morand, Grégoire B., et al.
Publicado: (2020)

Chemoradiation with Cisplatin vs. Carboplatin for Squamous Cell Carcinoma of the Head and Neck (SCCHN)
por: Rades, Dirk, et al.
Publicado: (2023)

Histological Regression of Squamous Esophageal Carcinoma Assessed by Percentage of Residual Viable Cells after Neoadjuvant Chemoradiation is an Important Prognostic Factor
por: Tong, Daniel King Hung, et al.
Publicado: (2010)

Radiation Sensitization of Basal Cell and Head and Neck Squamous Cell Carcinoma by the Hedgehog Pathway Inhibitor Vismodegib
por: Hehlgans, Stephanie, et al.
Publicado: (2018)

Clinicopathological Parameters Predicting Nodal Metastasis in Head and Neck Squamous Cell Carcinoma
por: Hashmi, Atif A, et al.
Publicado: (2023)

FLT PET Radiomics for Response Prediction to Chemoradiation Therapy in Head and Neck Squamous Cell Cancer
por: Ulrich, Ethan J., et al.
Publicado: (2019)

Yes-Associated Protein Expression in Head and Neck Squamous Cell Carcinoma Nodal Metastasis
por: Ge, Lin, et al.
Publicado: (2011)

The need for early detection of neck nodal metastasis in squamous cell carcinoma of oral cavity
por: Kumaran, P. Satish, et al.
Publicado: (2012)

Evolution of Head and Neck Cutaneous Squamous Cell Carcinoma Nodal Staging—An Australian Perspective
por: Hurrell, Michael J. L., et al.
Publicado: (2022)

Overall Neutrophil-to-Lymphocyte Ratio and SUV(max) of Nodal Metastases Predict Outcome in Head and Neck Cancer Before Chemoradiation
por: Werner, Jonas, et al.
Publicado: (2021)

Improved diagnostic accuracy of hybrid positron emission tomography (PET) with tumor-specific radiotracer for head and neck squamous cell carcinoma staging
por: Morand, Grégoire B., et al.
Publicado: (2023)

Chemoradiation and the Role of Adjuvant Chemotherapy in Lymph Nodal–Metastatic Cervical Cancer
por: Ali, Nasir, et al.
Publicado: (2017)

Nodal staging in rectal cancer: why is restaging after chemoradiation more accurate than primary nodal staging?
por: Heijnen, Luc A., et al.
Publicado: (2016)

Cost‐effectiveness of chemoradiation followed by esophagectomy versus chemoradiation alone in squamous cell carcinoma of the esophagus
por: Salcedo, Jonathan, et al.
Publicado: (2019)

Analysis of selected risk factors for nodal metastases in head and neck cutaneous squamous cell carcinoma
por: Szewczyk, Mateusz, et al.
Publicado: (2014)

Outcomes for patients with head and neck squamous cell carcinoma presenting with N3 nodal disease
por: Witek, Matthew E., et al.
Publicado: (2017)

Prognostic value of the nodal yield in head and neck squamous cell carcinoma: A systematic review
por: de Kort, Willem W. B., et al.
Publicado: (2019)

Predictive Value of Pretherapeutic Maximum Standardized Uptake Value (Suv(max)) In Laryngeal and Hypopharyngeal Cancer
por: Werner, Jonas, et al.
Publicado: (2019)

Prognostic factors of head and neck cutaneous squamous cell carcinoma: a systematic review
por: Lubov, Joshua, et al.
Publicado: (2021)

Expanding the clinicopathological spectrum of TGFBR3‐PLAG1 rearranged salivary gland neoplasms with myoepithelial differentiation including evidence of high‐grade transformation
por: Rupp, Niels J., et al.
Publicado: (2021)

Targeted Therapies and Immune-Checkpoint Inhibition in Head and Neck Squamous Cell Carcinoma: Where Do We Stand Today and Where to Go?
por: von der Grün, Jens, et al.
Publicado: (2019)

Diagnostic performance of core needle biopsy for nodal recurrences in patients with head and neck squamous cell carcinoma
por: Lo, Ta-Hsuan, et al.
Publicado: (2022)

Concurrent Chemoradiation with Low-Dose Weekly Cisplatin in Locally Advanced Stage IV Head and Neck Squamous Cell Carcinoma
por: Kang, Myoung Hee, et al.
Publicado: (2015)

Expression of the E-cadherin-catenin cell adhesion complex in primary squamous cell carcinomas of the head and neck and their nodal metastases.
por: Andrews, N. A., et al.
Publicado: (1997)

A survey on pulmonary screening practices among otolaryngology-head & neck surgeons across Canada in the post treatment surveillance of head and neck squamous cell carcinoma
por: Madana, J, et al.
Publicado: (2015)

Effect of sorafenib on cisplatin-based chemoradiation in head and neck cancer cells
por: Möckelmann, Nikolaus, et al.
Publicado: (2016)

Correlations Between DCE MRI and Histopathological Parameters in Head and Neck Squamous Cell Carcinoma()
por: Surov, Alexey, et al.
Publicado: (2016)

CT Texture Analysis—Correlations With Histopathology Parameters in Head and Neck Squamous Cell Carcinomas
por: Meyer, Hans-Jonas, et al.
Publicado: (2019)

ERCC1 expression as a predictive marker of squamous cell carcinoma of the head and neck treated with cisplatin-based concurrent chemoradiation
por: Jun, H J, et al.
Publicado: (2008)

Association of Nonsteroidal Anti-inflammatory Drug Use With Survival in Patients With Squamous Cell Carcinoma of the Head and Neck Treated With Chemoradiation Therapy
por: Iovoli, Austin J., et al.
Publicado: (2020)

Post-Operative Concurrent Chemoradiation for Patients with Non-Squamous Cell Carcinoma of Head and Neck: A Retrospective Cohort of the Uncommon Cancers
por: Thamlikitkul, Lucksamon, et al.
Publicado: (2019)

Valproic acid combined with cisplatin-based chemoradiation in locally advanced head and neck squamous cell carcinoma patients and associated biomarkers
por: Mak, Milena Perez, et al.
Publicado: (2020)

Neoadjuvant Concurrent Chemoradiation for Curative Treatment of Penile Squamous Cell Carcinoma
por: Chhabra, Arpit, et al.
Publicado: (2014)

Neoadjuvant versus definitive chemoradiation in patients with squamous cell carcinoma of the esophagus
por: Münch, Stefan, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_t1vc9jpflcm12pdm7f9jrkovbj